HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Keith D Amos Selected Research
Keith D Amos Research Topics
Disease
9
Neoplasms (Cancer)
01/2015 - 01/2003
7
Breast Neoplasms (Breast Cancer)
01/2015 - 01/2003
2
Pathologic Complete Response
05/2013 - 01/2012
1
Noninfiltrating Intraductal Carcinoma (DCIS)
01/2013
1
Hyperplasia
01/2013
1
Aggressive Fibromatosis (Desmoid)
03/2012
1
Fibrosis (Cirrhosis)
03/2012
1
Triple Negative Breast Neoplasms
01/2012
1
Pancreatic Neoplasms (Pancreatic Cancer)
02/2008
1
Adenocarcinoma
02/2008
Drug/Important Bio-Agent (IBA)
2
Estrogens (Estrogen)
FDA Link
05/2013 - 03/2012
2
Phenobarbital (Luminal)
FDA Link
01/2013 - 10/2011
1
Progesterone Receptors (Progesterone Receptor)
IBA
05/2013
1
Trastuzumab (Herceptin)
FDA Link
05/2013
1
human ERBB2 protein
IBA
05/2013
1
Hormones (Hormone)
IBA
05/2013
1
RNA (Ribonucleic Acid)
IBA
03/2012
1
Transforming Growth Factor beta (TGF-beta)
IBA
03/2012
1
Twist-Related Protein 1
IBA
03/2012
1
Claudins
IBA
03/2012
1
Biomarkers (Surrogate Marker)
IBA
01/2012
1
Estrogen Receptors
IBA
08/2011
1
Tumor Viral Antigens (Large T Antigen)
IBA
02/2008
1
Conditioned Culture Media
IBA
02/2008
1
Telomerase (Telomerase Reverse Transcriptase)
IBA
02/2008
1
Mitogen-Activated Protein Kinases
IBA
02/2008
1
Agar
IBA
02/2008
1
Gemcitabine
FDA Link
02/2008
1
Interferon-gamma (Interferon, gamma)
IBA
01/2003
1
Antigens
IBA
01/2003
1
Vaccines
IBA
01/2003
1
Mammaglobin A
IBA
01/2003
1
HLA-A2 Antigen (HLA A2 Antigen)
IBA
01/2003
1
Immunosorbents
IBA
01/2003
1
Enzymes
IBA
01/2003
1
HLA-A24 Antigen
IBA
01/2003
1
Peptides (Polypeptides)
IBA
01/2003
Therapy/Procedure
3
Neoadjuvant Therapy
01/2015 - 10/2011
2
Therapeutics
02/2008 - 01/2003
1
Resistance Training
03/2014
1
Mammaplasty (Breast Reconstruction)
01/2013
1
Drug Therapy (Chemotherapy)
01/2012
1
Segmental Mastectomy (Lumpectomy)
08/2011
1
Radiotherapy
02/2008